Healthcare- and technology-focused investor Polaris Partners named Isaac Ciechanover as a partner.
Ciechanover, who will be based in the firm's San Francisco office, joins from Atara Biotherapeutics Inc., an off-the-shelf T-cell immunotherapy company, where he was CEO.